Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
7.75
-0.10
(-1.27%)
At close: February 28 at 8:01:15 AM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
12,744,000
12,744,000
8,700,000
29,267,000
32,580,000
Investing Cash Flow
2,652,000
2,652,000
-32,278,000
-15,783,000
-22,546,000
Financing Cash Flow
-17,140,000
-17,140,000
26,066,000
-14,834,000
-9,816,000
End Cash Position
1,107,000
1,107,000
2,917,000
468,000
1,983,000
Income Tax Paid Supplemental Data
3,605,000
3,605,000
3,147,000
7,867,000
7,427,000
Interest Paid Supplemental Data
3,227,000
3,227,000
2,215,000
1,442,000
1,467,000
Capital Expenditure
-2,909,000
-2,909,000
-3,907,000
-3,236,000
-2,711,000
Issuance of Debt
8,907,000
8,907,000
38,517,000
3,891,000
997,000
Repayment of Debt
-16,066,000
-16,066,000
-2,572,000
-7,407,000
-2,100,000
Repurchase of Capital Stock
--
--
--
-2,000,000
--
Free Cash Flow
9,835,000
9,835,000
4,793,000
26,031,000
29,869,000
12/31/2021 - 2/15/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIIB.BA Biogen Inc.
13,125.00
0.00%
IDP.SG Biogen Inc
134.15
-0.26%
NOVN.SW Novartis AG
97.66
+0.05%
AZN.L AstraZeneca PLC
11,968.00
-0.42%
NOVO-B.CO Novo Nordisk A/S
644.50
+0.42%
GILD Gilead Sciences, Inc.
114.31
+2.07%
MRK Merck & Co., Inc.
92.25
+1.84%
JNJ Johnson & Johnson
165.02
+0.79%
LLY Eli Lilly and Company
920.63
+1.71%